2014 STARPHARMA (SLP7013-017)

“A phase 3, double-blind, multicentre, randomised, placebo-controlled study to determine the efficacy and safety of SPL7013 Gel (VivaGel®) to prevent the recurrence of bacterial vaginosis”

Your Name (required)

Your Email (required)

Subject

Your Message

Please insert the following text to probe you are not a robot
captcha